Robotics & Automation News

Market trends and business perspectives

cancer

Kuka unveils robotics for modern treatment of tumors

by Leave a Comment

A Munich therapy center uses a medical product with an integrated Kuka robot as a high-precision instrument in tumor treatment.

The CyberKnife system of Accuray, a kind of virtual knife, is an alternative to conventional radiotherapy.

Thanks to high-precision robot- and image-guided irradiation, the CyberKnife Center in Munich is able to treat tumors anywhere in the body – from the brain to the spinal column to various organs, such as the lungs, liver, kidneys or prostate. [Read more…] about Kuka unveils robotics for modern treatment of tumors

Stäubli Robotics and Quantum Surgical create ‘centre of excellence’ to develop oncology robotics

by Leave a Comment

Stäubli Robotics and Quantum Surgical have launched a strategic partnership to create a centre of excellence in oncology robotics.

The alliance aims to strengthen the role of robotics in minimally invasive cancer treatments and to use the combined expertise of each company to create a world leader in patient care.

Quantum Surgical, an innovative surgical robotic company, is developing an innovative solution, that combines powerful software and a robotic platform to offer minimally invasive therapies in liver cancer. [Read more…] about Stäubli Robotics and Quantum Surgical create ‘centre of excellence’ to develop oncology robotics

Broad cancer vaccine may be out of reach

by

vaccination

The high level of genetic diversity between individual tumors suggests that if it were to be developed, a broad cancer vaccine would be unlikely to work for more than 0.3 per cent of the population, according to new research published in the open access journal Genome Medicine.

Next generation sequencing has revealed a wealth of information on the genetic diversity of tumors, which in turn has led to research into individualised treatments for cancer based on the molecular characteristics of a patient’s tumor.

Cancer vaccines are one type of prospective treatment that involves turning the patient’s immune system against the tumor.

Dr Ryan Hartmaier, lead author from Foundation Medicine, USA, said: “A broad or semi-universal vaccine capable of targeting many different tumors would be seen by some as the ‘holy grail’ of cancer therapy as it wouldn’t involve the time or cost of individualising treatment.  [Read more…] about Broad cancer vaccine may be out of reach